New Delhi: The government panel National Technical Advisory Group on Immunisation (NTAGI) has recommended increasing the gap between two doses of Covishield to 12-16 weeks, sources said on Thursday (May 13).
The panel has also suggested that pregnant women may be offered the choice to take any COVID-19 vaccine and that lactating women will be eligible for vaccination any time after delivery. According to sources, NTAGI has stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery.
Currently, the interval between two doses of Covishield is four to eight weeks. NTAGI has not suggested any change in dosage interval for COVAXIN. The recommendations of the NTAGI will be sent to the National Expert Group on Vaccine Adminstration for COVID-19.
Meanwhile after recording more than 4-lakh COVID cases for four consecutive day till Sunday, India reported more than 3,62,000 new infections in the last 24 hours. As per the Ministry of Health and Family Welfare the country recorded 3,62,727 new COVID-19 cases on Thursday morning. A significant increase of nearly 12,000 cases was seen from a previous day high of 3,48,421 infections on May 12.
These new COVID-19 cases has pushed the country’s total tally to 2,37,03,665 in the country as on May 13. As per the Ministry of Health and Family Welfare, more than 4,100 deaths were reported in India. As per the ministry, as many as 4,120 mortalities were reported, an increase from previous day in the last 24 hours. On Wednesday, 4,205 deaths due to the novel coronavirus was reported. With more than 4,100 deaths the total death tally in the country rose to 2,58,317 lives lost to date.
On the recovery side, 3,52,181 discharges were recorded in the last 24 hours, Ministry of health data showed on Thursday morning. The data points that there was a slight decrease in discharges from the previous day. The total number of patients that have been discharged stood at 1,97,34,823 cases in the country on May 13.